1. Home
  2. ANIX vs TYGO Comparison

ANIX vs TYGO Comparison

Compare ANIX & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.49

Market Cap

119.8M

Sector

Health Care

ML Signal

HOLD

Logo Tigo Energy Inc.

TYGO

Tigo Energy Inc.

HOLD

Current Price

$1.10

Market Cap

129.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
TYGO
Founded
1982
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
119.8M
129.0M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ANIX
TYGO
Price
$3.49
$1.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$8.67
$6.00
AVG Volume (30 Days)
209.9K
1.5M
Earning Date
05-27-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
97.12
EPS
N/A
0.01
Revenue
$210,000.00
$103,536,000.00
Revenue This Year
N/A
$30.78
Revenue Next Year
N/A
$21.68
P/E Ratio
N/A
$111.00
Revenue Growth
N/A
91.68
52 Week Low
$2.32
$0.93
52 Week High
$5.46
$5.33

Technical Indicators

Market Signals
Indicator
ANIX
TYGO
Relative Strength Index (RSI) 58.73 35.93
Support Level $2.73 $0.93
Resistance Level $3.89 $1.73
Average True Range (ATR) 0.20 0.07
MACD 0.01 0.03
Stochastic Oscillator 69.92 44.00

Price Performance

Historical Comparison
ANIX
TYGO

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About TYGO Tigo Energy Inc.

Tigo Energy Inc provides solar and energy storage solutions, including module level power electronics (MLPE) designed to maximize the energy output of individual solar modules, delivering more energy, active management, and enhanced safety for utility, commercial, and residential solar arrays. By combining its MLPE and solar optimizer technology with intelligent, cloud-based software capabilities, the Company enables developed energy monitoring, system diagnostics, and real-time control. Geographically the company generates revenue from EMEA, Americas, and APAC.

Share on Social Networks: